At 24 months' follow-up, the only phase 3 randomized clinical trial to directly compare functional and oncologic outcomes between robot-assisted laparoscopic prostatectomy and open radical retropubic ...
– First multicenter, randomized controlled trial directly comparing a new technology to robotic RP for men with localized prostate cancer to successfully recruit to target enrollment – – TULSA ...
A major medical breakthrough has been achieved in Greece after, for the first time, a patient underwent surgery performed by a doctor located 8,000 kilometres away, in China.
Comorbid Diseases Lessen Survival Benefit of Aggressive PCa Therapy Growth in robot-assisted radical prostatectomy (RARP) use especially pronounced among surgeons at urban hospitals. Robot-assisted ...
PROCEPT BioRobotics Corp. (NASDAQ:PRCT) is one of the 10 best robotics and automation stocks to invest in. On May 28, PROCEPT ...
Apa-RP: Multicenter phase 2 study of apalutamide (Apa) and androgen deprivation therapy (ADT) for the treatment of high-risk localized prostate cancer (HR LPC) following radical prostatectomy ...
NEW DELHI: (Jun 20) A 68-year-old man diagnosed with locally advanced prostate cancer has undergone a complex robotic-assisted surgery at a Delhi hospital, according to a statement issued by the ...
He ultimately underwent a prostate needle biopsy, with 3 of 8 cores containing Gleason score 4+3 adenocarcinoma. Imaging did ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results